Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Suppressor of cytokine signaling 3
(
SOCS3
) is expressed by lymphoid cells and can modulate the sensitivity of these cells to cytokine stimulation through inhibition of Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathways. This study employed a mouse pro-B cell line expressing the human GH receptor (BaF/3-GHR), to elucidate the signal transduction pathways used by GH to elicit
SOCS3
expression. GH treatment of these cells caused a rapid, dose-dependent increase in
SOCS3
mRNA expression, which was independent of de novo protein synthesis. As expected, GH treatment increased JAK-dependent STAT5 tyrosine phosphorylation, which bound to the proximal STAT response element (pSRE) on the
SOCS3
promoter. This process appeared to involve STAT5b, rather than STAT5a. In addition, GH activation of the
SOCS3
promoter required a nearby activator protein (AP) 1/cAMP response element (CRE), which bound cAMP response element binding protein, c-Fos, and
c-Jun
. Moreover, inhibitors of p38 MAPK and c-Jun N-terminal kinase prevented GH-stimulation of
SOCS3
mRNA expression in these cells, suggesting a role for these kinases in
SOCS3
transcription. Importantly, GH stimulation increased binding of FOXO3a to the
SOCS3
promoter at a site overlapping the AP1/CRE response element, and overexpression of FOXO3a in these cells augmented
SOCS3
promoter activation. In addition, we show a direct interaction between FOXO3a and STAT5 in these cells, which may provide a link between STAT5 and the AP1 transcription factors on the
SOCS3
promoter. We conclude that regulation of
SOCS3
expression by GH in a pro-B cell involves not only the pSRE, but also a transcriptionally active complex involving cAMP response element binding protein/c-Fos/
c-Jun
and FOXO3a. This study has implications for cytokine regulation of SOCS gene expression in lymphoid cells.
...
PMID:Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. 1760 38